Classification is based on semantic text similarity scoring and may include approximations. “No match” means no high-confidence textual match was found — not necessarily that a section was removed.
🟢 New in Current Filing
We are exposed to risks as a result of our strategic actions.
🔒
🟢 New in Current Filing
We have experienced disruptions in our supply chain.
🔒
🟢 New in Current Filing
Continued consolidation in the health care industry or additional governmental controls exerted over pricing and access in key markets could lead to increased demands for price concessions or limit or eliminate our ability to sell to certain of our significant market segments.
🔒
🟢 New in Current Filing
We may be unable to obtain sufficient components or raw materials on a timely basis or for a cost-effective price.
🔒
🔴 No Match in Current Filing
Risks Relating to Our Strategic Actions
🔒
🔴 No Match in Current Filing
Risks Relating to Our Business
🔒
🔴 No Match in Current Filing
We may continue to experience difficulties with our ongoing integration of Hillrom or fail to realize the anticipated benefits of the Hillrom acquisition.
🔒
🔴 No Match in Current Filing
If our business strategy and development activities are unsuccessful, our business, results of operations, financial condition and cash flows could be adversely affected.
🔒
🔴 No Match in Current Filing
Pandemics and other public health emergencies, or the fear thereof, have had, and may in the future have, a material adverse effect on our business. The nature and extent of future impacts are uncertain and unpredictable.
🔒
🟡 Modified
We are subject to laws and regulations globally, and our failure to comply with rapidly changing and increasingly divergent expectations of regulators in different jurisdictions could adversely impact the company.
🔒
🟡 Modified
If we are unable to protect or enforce our patents or other proprietary rights, or if we become subject to claims or litigation alleging infringement of the patents or other proprietary rights of others, our competitiveness and business prospects may be materially damaged.
🔒
🟡 Modified
We are party to a number of pending lawsuits and other disputes which may adversely impact us.
🔒
🟡 Modified
Our common stock price has fluctuated significantly and may continue to do so in the future.
🔒
🟡 Modified
We are subject to risks associated with doing business globally.
🔒
🟡 Modified
Risks Relating to Legal and Regulatory Matters
🔒
🟡 Modified
Future material impairments in the value of our goodwill, intangible assets, and other long-lived assets would negatively affect our operating results.
🔒
🟡 Modified
There is substantial competition in the product markets in which we operate and the risk of declining demand and pricing pressures could adversely affect our business, results of operations, financial condition and cash flows.
🔒
🟡 Modified
We may not achieve our financial goals.
🔒
🟡 Modified
We may experience breaches and breakdowns affecting our information technology systems or protected information, including from obsolescence, cyber security breaches and data leakage.
🔒
🟡 Modified
We have experienced and may continue to experience issues with quality management or product quality.
🔒
🟡 Modified
reform or other similar actions, cost containment measures, or there are changes to policies with respect to pricing, taxation, or rebates, our business could suffer.
🔒
🟡 Modified
We may experience manufacturing, sterilization, supply, or distribution difficulties.
🔒
🟡 Modified
We may not be successful in achieving expected operating efficiencies and sustaining or improving operating expense reductions and may experience business disruptions and adverse tax consequences associated with restructuring initiatives.
🔒
🟡 Modified
The effects of climate change, including legal, regulatory, or market measures related to climate change and other sustainability topics, could adversely affect our business, results of operations, financial condition, and cash flows.
🔒
🟡 Modified
Global economic conditions, including inflation, have adversely affected, and could continue to adversely affect, our operations.
🔒
🟡 Modified
Increasing regulatory focus on, and expanding laws relating to, privacy, AI, and cybersecurity could impact our business and expose us to increased liability.
🔒
🟡 Modified
Risks Relating to Our Operations
🔒
🟡 Modified
We are exposed to risks associated with incorporating AI, machine learning and other emerging technologies into our products, services and operations.
🔒
🟡 Modified
Our significant indebtedness requires us to use a substantial amount of our cash flow for debt service and constrains our ability to pursue growth strategies and advance our R&D capabilities.
🔒
🟡 Modified
We may not achieve the anticipated benefits of our significant transactions, including the sale of our Kidney Care business and our acquisition of Hillrom.
🔒
🟡 Modified
We may incur additional tax expense or become subject to additional tax liabilities.
🔒
🟡 Modified
Our commitments, goals, activities, and disclosures related to sustainability and corporate responsibility matters, and the perception of our activities in these areas, may fail to satisfy the differing expectations of key stakeholders on these matters.
🔒
🟡 Modified
We recently decreased our quarterly dividend to $0.01 per share and cannot guarantee that we will increase the amount of dividends we pay, or that we will not cease paying dividends.
🔒
🟡 Modified
Risks Relating to Our Business and Financial Performance
🔒
🟡 Modified
Management transition creates uncertainties, and any difficulties we experience in managing such transitions, including attracting and retaining our key employees, could adversely affect our business and results of operations.
🔒